#3690
Development of a novel NET-nutrition screening tool to identify patients requiring nutrition-related intervention and support
Introduction:
Patients with neuroendocrine tumors (NET) are at risk of malnutrition, nutrient malabsorption and dietary change. Existing validated malnutrition risk screening tools are not designed to capture complex NET-related nutrition issues.
Conference:
Presenting Author:
Laing E
Authors:
Laing E,
Kiss N,
Loeliger J,
Steer B,
Michael M,
Keywords:
neuroendocrine,
nutrition,
screening,
diet,
#2179
Exploring Nutrition Screening and Management Practices amongst Health Professionals Managing Patients with Neuroendocrine Tumors
Introduction:
Patient’s with neuroendocrine tumours (NET) are at nutritional risk due to symptoms and side-effects of treatment. Current evidence based guidelines lack information regarding optimal nutritional management and supportive care.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Kennedy E
Authors:
Kennedy E,
Kiss N,
Michael M,
Gough K,
Drosdowsky A,
Keywords:
neuroendocrine,
health professional,
nutrition,
symptoms,
malnutrition,
#2078
Self-Reported Side Effects in Neuroendocrine Tumor (NET) Patients Prescribed Somatostatin Analogues – The Role for Specialist Dietitians and Nurses
Introduction:
In practice, many patients with NETs report a change in symptoms after starting somatostatin analogues (SSA’s). Many health professionals and NET patient advocates have noticed that some of the side effects experienced by patients are more common than patient information literature suggests. It is therefore important to ask what and how severe experiences are, and compare to literature, to help raise awareness amongst NET health professionals.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Authors:
Whyand T,
Davies P,
Bouvier C,
Keywords:
B12,
SSA,
Side effects,
Fat soluble vitamins,
